Paper40104652
An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment.
Lei D and 12 others. Mater Today Bio, 2025. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment. Papers, record 40104652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40104652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16327177 | Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid. | Biol Pharm Bull | 2005 | https://conductscience.org/library/papers/16327177 | PubMed |
| 2 | 38008741 | Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/38008741 | PubMed |
| 3 | 33524560 | An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway. | Acta Biomater | 2021 | https://conductscience.org/library/papers/33524560 | PubMed |
| 4 | 38689426 | Engineered Bacteriophage-Based In Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity. | ACS Nano | 2024 | https://conductscience.org/library/papers/38689426 | PubMed |
| 5 | 38291516 | Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/38291516 | PubMed |
| 6 | 31863820 | Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. | Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31863820 | PubMed |
| 7 | 38136565 | The Structural-Functional Crosstalk of the Calsequestrin System: Insights and Pathological Implications. | Biomolecules | 2023 | https://conductscience.org/library/papers/38136565 | PubMed |
| 8 | 23707350 | Nitric oxide induces apoptosis associated with TRPV1 channel-mediated Ca(2+) entry via S-nitrosylation in osteoblasts. | Eur J Pharmacol | 2013 | https://conductscience.org/library/papers/23707350 | PubMed |
| 9 | 26876480 | Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. | Sci Rep | 2016 | https://conductscience.org/library/papers/26876480 | PubMed |
| 10 | 24878889 | Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula. | Cancer Immunol Immunother | 2014 | https://conductscience.org/library/papers/24878889 | PubMed |
| 11 | 27911871 | Inhibition of cancer antioxidant defense by natural compounds. | Oncotarget | 2017 | https://conductscience.org/library/papers/27911871 | PubMed |
| 12 | 37183170 | Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi-active components combination. | Med Res Rev | 2023 | https://conductscience.org/library/papers/37183170 | PubMed |
| 13 | 18339865 | Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. | Cancer Res | 2008 | https://conductscience.org/library/papers/18339865 | PubMed |
| 14 | 39328776 | Immune-modulative nano-gel-nano system for patient-favorable cancer therapy. | Bioact Mater | 2025 | https://conductscience.org/library/papers/39328776 | PubMed |
| 15 | 23936062 | Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles. | PLoS One | 2013 | https://conductscience.org/library/papers/23936062 | PubMed |
| 16 | 39142275 | Resident memory T cells and cancer. | Immunity | 2024 | https://conductscience.org/library/papers/39142275 | PubMed |
| 17 | 30316995 | Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld's syndrome): A new flame. | Autoimmun Rev | 2018 | https://conductscience.org/library/papers/30316995 | PubMed |
| 18 | 23201688 | Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids. | Nature | 2013 | https://conductscience.org/library/papers/23201688 | PubMed |
| 19 | 23280371 | Pharmacokinetic considerations for targeted drug delivery. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/23280371 | PubMed |
| 20 | 37159807 | Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37159807 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42929971 | Traditional Chinese Medicine-Associated Bioactive Hydrogels: Material Roles, Network Design, and Therapeutic Applications. | Gels | 2026 | https://conductscience.org/library/papers/42929971 | PubMed |
| 42776349 | Nanoparticle delivery of Chinese medicine monomers for remodeling the colorectal cancer immune microenvironment. | Discov Nano | 2026 | https://conductscience.org/library/papers/42776349 | PubMed |
| 42646677 | Bidirectional Interplay Between Tumor Vaccines and the Tumor Microenvironment: Mechanisms, Cold-to-Hot Conversion, and Combination Strategies. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646677 | PubMed |
| 42368584 | Smart responsive hydrogels combined with AI design for tumor therapy. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368584 | PubMed |
| 42363193 | Herb-derived immunometabolic modulators: traditional Chinese medicine at the crossroads of metabolism and antitumor immunity. | Chin Med | 2026 | https://conductscience.org/library/papers/42363193 | PubMed |
| 42283951 | Intratumoral Injectable Click-Crosslinked Hyaluronic Acid Depot for Sustained Gemcitabine Delivery. | Tissue Eng Regen Med | 2026 | https://conductscience.org/library/papers/42283951 | PubMed |
| 42237349 | Gambogic acid induces cell death via covalent binding with PRDX1 to regulate ER stress and autophagy. | Chin Med | 2026 | https://conductscience.org/library/papers/42237349 | PubMed |
| 42174630 | Tetrandrine-based in situ vaccination via multifunctional Mn²⁺-hyaluronic acid hydrogel loading gelatinase-responsive nanoparticles. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42174630 | PubMed |
| 41639348 | Gambogic acid ameliorates hepatocellular carcinoma by inhibiting oxidative stress via Nrf2-pSmad2C/2L pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41639348 | PubMed |
| 41311720 | Multi-targeted pharmacological actions and nanodelivery strategies of Garcinia cambogia: from molecular mechanisms to disease treatment. | Front Chem | 2025 | https://conductscience.org/library/papers/41311720 | PubMed |
| 41215767 | Harnessing light: Synthesis, mechanisms, and pre-clinical biomedical applications of stimuli-responsive multiscale composites. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41215767 | PubMed |
| 40900835 | Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40900835 | PubMed |
| 40682067 | Single-cell RNA sequencing technology was employed to construct a risk prediction model for genes associated with pyroptosis and ferroptosis in lung adenocarcinoma. | Respir Res | 2025 | https://conductscience.org/library/papers/40682067 | PubMed |
| 40520059 | Multifaceted Applications of Nanomaterials in Colorectal Cancer Management: Screening, Diagnostics, and Therapeutics. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40520059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40104652
GET https://conductscience.org/api/papers/v1/40104652/references?page=2